Clipping da Concorrência – 14.12


Notícias

Senado aprova indicações de conselheiros para o Cade

Statement Regarding the Termination of Sanofi’s Proposed Acquisition of Maze Therapeutics’ Pompe Disease Drug

FTC Announces CARS Rule to Fight Scams in Vehicle Shopping

Commission clears Novozymes and Chr. Hansen merger, subject to conditions

Protection des données et concurrence : la CNIL et l’Autorité de la concurrence signent une déclaration conjointe

Unilever’s ‘green’ claims come under CMA microscope

Referral of the proposed subsidy to BMW UK Manufacturing Limited by the Department for Business and Trade


Casos

CADE

Ato de Concentração nº 08700.008401/2023-27

Requerentes: Petlove Tecnologia Ltda., Gurgelmix Máquinas e Ferramentas S.A. e Bit Services Inovação e Tecnologia Ltda. Advogados: Barbara Rosenberg, Maria Sampaio e Bruna Silveira de Alencar. Decido pela aprovação sem restrições. Publique-se.

Ato de Concentração nº 08700.008465/2023-28

Requerentes: HOLON GmbH e Volkswagen AG. Advogados: Daniel O. Andreoli e Raphael Póvoas. Decido pelo não conhecimento da operação. Publique-se.

Ato de Concentração nº 08700.008447/2023-46

Requerentes: Riva Incorporadora S.A. e Interlagos Empreendimentos e Participações Ltda. Advogados: Luiz Eduardo Salles, Lucas Mandelbaum Bianchini, Ana Clara Appolinário de Almeida e Marco Chung. Decido pela aprovação sem restrições. Publique-se.

Ato de Concentração nº 08700.008123/2023-16

Requerentes: Clariant International AG e International Flavors & Fragrances, Inc. Advogados: Alberto Monteiro e Fernanda Lins Nemer. Decido pela aprovação sem restrições. Publique-se.


FTC

Sanofi/Maze Therapeutics, Inc., In the Matter of

On December 13, 2023, the FTC moved to dismiss its case challenging the transaction following Sanofi’s decision to terminate its transaction with Maze Therapeutics Inc.

Type of Action

Administrative

Last Updated

December 13, 2023

FTC Matter/File Number

2310091

Docket Number

9422

Case Status

Pending


John Muir Health/Tenet Healthcare Co., In the Matter of

The Federal Trade Commission sued to block John Muir Health’s proposed $142.5 million deal to acquire sole ownership of San Ramon Regional Medical Center, LLC from current majority owner Tenet Healthcare Corporation, saying the deal will drive up health care costs.

The Commission issued an administrative complaint and authorized a lawsuit in federal court alleging the proposed acquisition will eliminate head-to-head competition between John Muir Health and nearby San Ramon Regional Medical Center 

Type of Action

Administrative

Last Updated

December 12, 2023

FTC Matter/File Number

2310054

Docket Number

9421

Case Status

Pending


Comissão Europeia

MERIDIAM / MGETS FUND / VERKOR

Merger

M.11293

Last decision date: 13.12.2023 Simplified procedure

BROMIA / RAFFEISENBANK INTERNATIONAL / RAIFFEISEN CONTINUUM MANAGEMENT

Merger

M.11273

Last decision date: 13.12.2023 Simplified procedure


CMA

ABP / Scotbeef assets merger inquiry

    • 14 December 2023
    • Competition and Markets Authority case